INTRODUCTION
============

Inflammatory bowel disease (IBD) is a chronic gastrointestinal inflammation, including Crohn's disease (CD) and ulcerative colitis (UC). It is a life-long idiopathic disorder and etiology is unknown.[@b1-gnl-09-756]

The number of pediatric patients with IBD has gradually increased over the last several decades.[@b2-gnl-09-756],[@b3-gnl-09-756] Approximately 15% to 25% of patients with IBD have the onset of their symptoms before 20 years of age.[@b4-gnl-09-756],[@b5-gnl-09-756] Previous epidemiological studies reported that characteristics of pediatric onset IBD differ from those of adults.[@b6-gnl-09-756] Incidence of IBD is greater among Caucasians than in other races, so the characteristics of pediatric onset IBD have been reported mainly from Western countries.[@b2-gnl-09-756],[@b7-gnl-09-756],[@b8-gnl-09-756]

Although IBD is rare in Korean children, increasing numbers of pediatric patients with IBD have been noted in recent years. However, there are few studies that have focused on pediatric onset IBD in Korea.[@b9-gnl-09-756]--[@b12-gnl-09-756] Furthermore there are no studies comparing Western pediatric IBD and Korean pediatric IBD patients. In an attempt to answer the question, we investigated the clinical characteristics of pediatric IBD in Korea and compare with cases reported from the 5-year European multicenter study of children with new-onset IBD (EUROKIDS registry).[@b13-gnl-09-756],[@b14-gnl-09-756]

MATERIALS AND METHODS
=====================

Five institutions in Korea participated in this retrospective study with the approval of each institutional review board: Kangbuk Samsung Hospital, Samsung Medical Center, Kyung Hee University Hospital, Konyang University Hospital, and St. Vincent's Hospital. The medical records from July 1987 through January 2012 were reviewed to identify patients who treated for IBD. All patients had to be \<18 years of age at diagnosis of IBD and diagnoses were confirmed by previously established international criteria based on clinical, endoscopic, histopathological, and radiological findings.[@b15-gnl-09-756] Disease location and disease behavior were classified according to the Montreal classification.[@b16-gnl-09-756] The extent of UC patients of EUROKIDS group were analyzed by the Paris classification, while our study used Montreal classification for data analysis. Therefore, we reanalyzed the extent of UC patients of EUROKIDS group using Montreal classification to compare the data from two different studies. In this reason, E2 and E3 of Paris classification were combined as a single E2 of Montreal classification and E4 of Paris classification are replaced E3.

Patients with less than 6 months of follow-up and incomplete clinical data were excluded.

The software program SPSS version 12.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analyses. The chi-square or Fisher exact test was used to compare categorical variables. p-values \<0.05 were considered statistically significant.

RESULTS
=======

A total of 30 children with CD and 33 children with UC were enrolled. [Fig. 1](#f1-gnl-09-756){ref-type="fig"} shows distribution of disease location and disease behavior in Korean pediatric patients with CD according to age at diagnosis. [Fig. 2](#f2-gnl-09-756){ref-type="fig"} shows distribution of disease extent in Korean pediatric patients with UC according to age at diagnosis.

In comparison with EUROKIDS group, Korean pediatric IBD patients showed male predominance (86.7% vs 59.2%, p=0.002 in CD; 75.8% vs 50%, p=0.003 in UC). The mean ages at diagnosis of Korean IBD children were older than EUROKIDS group (15.3 years vs 12.5 years in CD; 15.8 years vs 11.6 years in UC) ([Table 1](#t1-gnl-09-756){ref-type="table"}).

[Table 2](#t2-gnl-09-756){ref-type="table"} shows the results comparing disease characteristics of pediatric CD in Korean group and EUROKIDS group. In comparison to EUROKIDS group, Korean children had higher rates of terminal ileal disease (36.7% vs 16.3%, p=0.004). There is no difference between Korean group and EUROKIDS group on disease behavior of CD, but perianal disease is higher rates in Korean children (33.3% vs 8.2%, p\<0.001).

The comparison of disease extent of pediatric UC patients in Korea and EUROKIDS was seen on the [Table 3](#t3-gnl-09-756){ref-type="table"}. Both groups showed high proportion of extensive disease (E3, Korea 57.6% and EUROKIDS 68.7%), and its prevalence was inversely correlated with age ([Fig. 2](#f2-gnl-09-756){ref-type="fig"}); however, Korean children had higher rates of proctitis than EUROKIDS group (18.2% vs 4.7%, p=0.001).

DISCUSSION
==========

This study is the first paper reporting the clinical characteristics of pediatric IBD in Korea based on multicenter data. We examined the clinical characteristics of pediatric IBD diagnosed in the five centers and compared our data with the data from EUROKIDS which is the largest pediatric IBD study conducted in Europe. There are several, significant differences in clinical characteristics between two groups. Pediatric CD patients in our study showed higher ratio in terms of terminal ileal disease and perianal disease than EUROKIDS patients. In case of pediatric UC patients, the ratio of proctitis was higher in Korean pediatric patients than EUROKIDS group.

Our study presented a marked male predominance in the pediatric CD patients (male:female ratio, 6.5:1). As the other studies of Korean pediatric CD also identified the male predominance, reporting male-to-female ratio of CD as 2:1, 2.2:1,[@b10-gnl-09-756],[@b11-gnl-09-756] this study reconfirmed the male predominance in Korea pediatric CD patients. Male predominance was also reported in recent Western pediatric studies, but EUROKIDS data did not showed sexual predominance.[@b7-gnl-09-756],[@b8-gnl-09-756],[@b13-gnl-09-756] Similar to our results, studies conducted in Asian countries, such as Korea, China, and Japan, reported male predominance, whereas the studies conducted in Western countries reported that there is no difference in sex ratio or even female predominance.[@b8-gnl-09-756],[@b17-gnl-09-756],[@b18-gnl-09-756]

In location of the CD, both our study group and EUROKIDS group reported about 50% in ileocolic disease (L3). The next largest group was terminal ileal disease (L1) in our study, but colonic disease (L2) in EUROKIDS study. Looking at the other pediatric CD studies conducted in Korea, they showed different results. In the case of Lee & Park,[@b11-gnl-09-756] this L1 predominance was observed as 33.3% and Kim *et al*.[@b10-gnl-09-756] reported 13% of L1 as shown in EUROKIDS group. Therefore, more studies are needed to verify whether L1 predominance than L2 disease is a main characteristic of Korean pediatric CD. Studies about adult CD in Korea also showed L1 predominance than L2.[@b19-gnl-09-756],[@b20-gnl-09-756]

The results of our study showed that the predominance of perianal disease can be the distinguishable difference in Asian and Western in pediatric CDs. Other studies about Korean pediatric CD also support the result of the current study, presenting that about half of the patients have perianal disease (50% to 54%).[@b10-gnl-09-756],[@b11-gnl-09-756] However, the studies conducted in Western countries reported perianal disease of pediatric CD as 8% to 14.5%.[@b21-gnl-09-756]--[@b24-gnl-09-756] Perianal disease has also seemed to be more commonly occurred in Korean adult CD patients than Western countries. Studies from Asian area reported 30% to 40% of perianal disease and studies from North America reported 13% to 38%.[@b19-gnl-09-756],[@b25-gnl-09-756]--[@b28-gnl-09-756]

Pediatiric UC patients also showed male predominance. However, the other Korean pediatric study about IBD reported female predominance, and Korean adult study reported no gender bias.[@b9-gnl-09-756],[@b10-gnl-09-756] Western study about UC have shown no sexual differences in either adults or children.[@b7-gnl-09-756],[@b8-gnl-09-756]

Our study showed high proportion of children of UC with extensive disease which was inversely correlated with age. EU-ROKIDS study also verified same result and it correspond with the previous literature.[@b14-gnl-09-756],[@b29-gnl-09-756],[@b30-gnl-09-756] Adult UC presented relatively less extensive disease than pediatric UC in both Western and Eastern and most frequent location of UC in adult UC varied between different studies.[@b31-gnl-09-756],[@b32-gnl-09-756]

Korean children with UC had higher proportion of proctitis (E1) than EUROKIDS group. Similar to the present study, a single-center study of pediatric IBD in Korea, reported that proctitis of Korean pediatric UC was 21%.[@b10-gnl-09-756] On the other hand, other pediatric UC studies in Western countries report that E1 was found less than 5% to 10%.[@b21-gnl-09-756],[@b23-gnl-09-756],[@b24-gnl-09-756]

Our study has some limitations. First, there is limited validation because of small amount of samples of this study comparing to the number of patients used in large studies such as EUROKIDS study. Because the incidence of IBD is low in Korea, and thus, the incidence of IBD in children is lower, absolute number of patients is inevitably small in Korea. However, it is believed that the results of our study can reflect tendency of Korean pediatric IBD, because the patients of this study were collected from five different hospitals in three provinces in Korea. Second, we used Montreal classification instead of Paris classification which can be more sophisticate in examining pediatrics.

In conclusion, Korean children with CD have higher prevalence of ileal disease and perianal disease and Korean children with UC have high prevalence of proctitis compared with EU-ROKIDS. Our results suggest that the characteristics of Korean pediatric IBD patients and European pediatric IBD patients may be different.
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![Disease location and disease behavior in children with Crohn's disease by age at diagnosis. (A) Disease location. (B) Disease behavior.\
L1, terminal ileal disease; L2, colonic disease; L3, ileocolonic disease; L4, concomitant upper gastrointestinal disease; B1, nonstricturing, non-penetrating; B2, stricturing; B3, penetrating.](gnl-09-756f1){#f1-gnl-09-756}

![Disease extent in children with ulcerative colitis (UC) by age at diagnosis.\
E1, ulcerative proctitis; E2, left-sided UC; E3, extensive UC.](gnl-09-756f2){#f2-gnl-09-756}

###### 

Patient Demographics at Diagnosis of Inflammatory Bowel Disease

  Demographics           Korean patients    EUROKIDS           p-value
  ---------------------- ------------------ ------------------ ---------
  CD                     n=30               n=1,221            
   Age at diagnosis      15.3 (6.9--17.9)   12.5 (0.8--17.9)   
    Sex                                                        0.002
     Male                26 (86.7)          723 (59.2)         
     Female              4 (13.3)           498 (40.8)         
     Male:female ratio   6.5:1              1.5:1              
  UC                     n=33               n=643              
   Age at diagnosis      15.8 (8.8--17.7)   11.6 (0.6--17.9)   
    Sex                                                        0.003
     Male                25 (75.8)          319 (49.6)         
     Female              8 (24.2)           324 (50.4)         
     Male:female ratio   3.1:1              1:1                

Data are presented as mean (range) or number (%).

CD, Crohn's disease; UC, ulcerative colitis.

###### 

Comparison of the Characteristics of Pediatric Crohn's Disease Patients in Korea and EUROKIDS, Using the Montreal Classification

  Characteristic                           Korean patients (n=30)   EUROKIDS (n=582)   p-value
  ---------------------------------------- ------------------------ ------------------ ---------
  Disease distribution                                                                 
   L1 (terminal ileal disease)             11 (36.7)                95 (16.3)          0.004
   L2 (colonic disease)                    4 (13.3)                 159 (27.3)         0.136
   L3 (ileocolonic disease)                15 (50.0)                307 (52.8)         0.769
   L4 (concomitant/isolated UGI disease)   1 (3.4)                  269 (46.2)         \<0.001
  Disease behavior                                                                     
   B1 (nonstricturing, nonpenetrating)     21 (70.0)                477 (82.0)         0.101
   B2 (stricturing)                        6 (20.0)                 77 (13.2)          0.291
   B3 (penetrating)                        3 (10.0)                 28 (4.8)           0.189
  Perianal disease                                                                     \<0.001
   Yes                                     10 (33.3)                48 (8.2)           
   No                                      20 (66.7)                534 (91.8)         

Data are presented as number (%).

UGI, upper gastrointestinal.

###### 

Comparison of the Characteristics of Pediatric Ulcerative Colitis Patients in Korea and EUROKIDS, Using the Montreal Classification

  Characteristic                                                   Korean patients (n=33)   EUROKIDS (n=578)                                        p-value
  ---------------------------------------------------------------- ------------------------ ------------------------------------------------------- ---------
  UC                                                                                                                                                
   E1 (ulcerative proctitis)                                       6 (18.2)                 27 (4.7)                                                0.001
   E2 (left-sided UC[\*](#tfn7-gnl-09-756){ref-type="table-fn"})   8 (24.2)                 154 (26.6)[†](#tfn8-gnl-09-756){ref-type="table-fn"}    0.761
   E3 (extensive UC[‡](#tfn9-gnl-09-756){ref-type="table-fn"})     19 (57.6)                397 (68.7)[§](#tfn10-gnl-09-756){ref-type="table-fn"}   0.183

Data are presented as number (%).

UC, ulcerative colitis.

Distal to splenic flexure;

E2 and E3 of the Paris classification;

Proximal to splenic flexure;

E4 of the Paris classification.
